Wall Street brokerages forecast that Express Scripts Holding Company (NASDAQ:ESRX) will announce sales of $25.67 billion for the current fiscal quarter, according to Zacks. Nine analysts have issued estimates for Express Scripts Holding’s earnings. The highest sales estimate is $26.07 billion and the lowest is $25.34 billion. Express Scripts Holding reported sales of $25.41 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 1%. The company is scheduled to report its next quarterly earnings results on Tuesday, October 24th.
On average, analysts expect that Express Scripts Holding will report full-year sales of $25.67 billion for the current financial year, with estimates ranging from $99.99 billion to $102.31 billion. For the next year, analysts anticipate that the firm will post sales of $103.44 billion per share, with estimates ranging from $100.40 billion to $106.25 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow Express Scripts Holding.
Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. During the same quarter in the prior year, the business earned $1.57 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis.
Several research analysts have weighed in on ESRX shares. ValuEngine cut Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. BidaskClub raised Express Scripts Holding from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Needham & Company LLC started coverage on Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating on the stock. Jefferies Group LLC set a $72.00 price objective on Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday. Finally, Cowen and Company reissued an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research report on Friday, June 9th. Four investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Express Scripts Holding presently has a consensus rating of “Hold” and an average price target of $70.03.
In related news, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the sale, the vice president now directly owns 18,232 shares in the company, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.68% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the stock. Burt Wealth Advisors raised its stake in Express Scripts Holding by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the last quarter. Dubuque Bank & Trust Co. raised its stake in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares during the last quarter. CKW Financial Group raised its stake in Express Scripts Holding by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares during the last quarter. TrimTabs Asset Management LLC bought a new stake in Express Scripts Holding during the first quarter worth about $121,000. Finally, Capital Analysts LLC raised its stake in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares during the last quarter. Institutional investors own 88.70% of the company’s stock.
Express Scripts Holding (NASDAQ ESRX) traded up 2.10% during midday trading on Monday, reaching $62.82. The company had a trading volume of 3,122,156 shares. The stock’s 50 day moving average is $61.86 and its 200 day moving average is $63.78. Express Scripts Holding has a 12-month low of $57.80 and a 12-month high of $77.50. The firm has a market capitalization of $36.28 billion, a price-to-earnings ratio of 10.90 and a beta of 0.90.
ILLEGAL ACTIVITY WARNING: “$25.67 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter” was first published by BBNS and is the sole property of of BBNS. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://baseballnewssource.com/markets/25-67-billion-in-sales-expected-for-express-scripts-holding-company-esrx-this-quarter/1565332.html.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with our FREE daily email newsletter.